Topic Highlight
Copyright ©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 28, 2007; 13(44): 5877-5887
Published online Nov 28, 2007. doi: 10.3748/wjg.v13.i44.5877
Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What’s new?
M Ponz-Sarvisé, J Rodríguez, A Viudez, A Chopitea, A Calvo, J García-Foncillas, I Gil-Bazo
M Ponz-Sarvisé, J Rodríguez, A Viudez, A Chopitea, J García-Foncillas, I Gil-Bazo, Oncology Department, Clínica Universitaria, Universidad de Navarra, Pamplona 31008, Spain
A Calvo, J García-Foncillas, I Gil-Bazo, Division of Oncology, CIMA, Spain
Author contributions: All authors contributed equally to the work.
Correspondence to: Ignacio Gil-Bazo, MD, PhD, Department of Oncology, University Clinic, University of Navarra, Pio XII, 36, Pamplona 31008, Spain. igbazo@unav.es
Telephone: +34-948-255400 Fax: +34-948-255400
Received: July 13, 2007
Revised: August 1, 2007
Accepted: October 22, 2007
Published online: November 28, 2007
Core Tip